PDF(Pubmed)
Abstract：
Recent increases in pediatric and adolescent opioid fatalities mandate an urgent need for early consideration of possible opioid exposure and specific diagnostic and management strategies and interventions tailored to these unique populations. In contrast to adults, pediatric methods of exposure include accidental ingestions, prescription misuse, and household exposure. Early recognition, appropriate diagnostic evaluation, along with specialized treatment for opioid toxicity in this demographic are discussed. A key focus is on Naloxone, an essential medication for opioid intoxication, addressing its unique challenges in pediatric use. Unique pediatric considerations include recognition of accidental ingestions in our youngest population, critical social aspects including home safety and intentional exposure, and harm reduction strategies, mainly through Naloxone distribution and education on safe medication practices. It calls for a multifaceted approach, including creating pediatric-specific guidelines, to combat the opioid crisis among children and to work to lower morbidity and mortality from opioid overdoses.
摘要：
最近儿科和青少年阿片类药物死亡人数的增加迫切需要及早考虑可能的阿片类药物暴露以及针对这些独特人群的特定诊断和管理策略和干预措施。与成年人相比，儿科接触方法包括意外摄入，处方误用，和家庭曝光。早期识别,适当的诊断评估，讨论了这种人口统计学中阿片类药物毒性的专门治疗方法。一个关键的焦点是纳洛酮,阿片类药物中毒的基本药物，解决其在儿科使用中的独特挑战。独特的儿科考虑因素包括在我们最年轻的人群中识别意外摄入，关键的社会方面，包括家庭安全和故意暴露，和减少伤害战略，主要通过纳洛酮分发和安全用药实践教育。它要求采取多方面的方法，包括创建儿科特定指南，与儿童阿片类药物危机作斗争，并努力降低阿片类药物过量的发病率和死亡率。
